Cardio-optics develops IR (infrared) imaging system for MIS (minimally invasive surgical)
This article was originally published in Clinica
A US company is developing an infrared, catheter-based imaging system for use in minimally invasive surgical procedures. The company, Cardio-optics, claims the system provides a much higher resolution than intravascular ultrasound (IVUS), which it believes is the only competitive product on the market.
You may also be interested in...
Seven pharmacies have filed a lawsuit against the FDA claiming the agency exceeded its statutory authority in its final standard memorandum of understanding on interstate compounding and that the MOU will have an adverse impact on compounding pharmacies and patients.
Several experts spoke with Scrip about their take on how the biopharmaceutical industry's efforts to respond to COVID-19 might help industry's image problem.
Pharma pays $50m up front to tap insitro’s in vitro modeling technology, partners with Sensyne Health in blood disorders. Lilly’s COVID-19 partner AbCellera teams with Kodiak in ophthalmology R&D.